With approximately 5000 new cases in 2020, prostate cancer is the most common cancer in Finland.
We explore RNA and protein expression of prostate cancer, finding new game-changing biomarkers. By using artificial intelligence, we create algorithms for cancer recognition in pathological H&E slides and MRI images, connecting this to patient data.
We seek to translate our findings into clinical everyday practice and empower the future of precision medicine.
029 41 21650